Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
João Mauricio Castaldelli-Maia, Victoria Camargos de Oliveira, Flávia Mariana Irber, Israel K. Blaas, Bernard Angerville, Anderson Sousa Martins-da-Silva, Gislaine Koch Gimenes, Marcela Waisman Campos, Julio Torales, Antonio Ventriglio, Carine Guillois, Houria El Ouazzani, Léna Gazaix, Pascal Favré, Alain Dervaux & Gisèle Apter. (2023) Psychopharmacology of smoking cessation medications: focus on patients with mental health disorders. International Review of Psychiatry 0:0, pages 1-21.
Read now
Read now
Scott Wilkes. (2008) The use of bupropion SR in cigarette smoking cessation. International Journal of Chronic Obstructive Pulmonary Disease 3:1, pages 45-53.
Read now
Read now
Articles from other publishers (18)
Frank T. Leone, Yuqing Zhang, Sarah Evers-Casey, A. Eden Evins, Michelle N. Eakin, Joelle Fathi, Kathleen Fennig, Patricia Folan, Panagis Galiatsatos, Hyma Gogineni, Stephen Kantrow, Hasmeena Kathuria, Thomas Lamphere, Enid Neptune, Manuel C. Pacheco, Smita Pakhale, David Prezant, David P. L. Sachs, Benjamin Toll, Dona Upson, Dan Xiao, Luciane Cruz-Lopes, Izabela Fulone, Rachael L. Murray, Kelly K. O’Brien, Sureka Pavalagantharajah, Stephanie Ross, Yuan Zhang, Meng Zhu & Harold J. Farber. (2020) Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine 202:2, pages e5-e31.
Crossref
Crossref
María Luisa González Moral, Carmen Selva Sevilla, Patricia Romero Rodenas, María Teresa Tolosa Pérez, Marta Lucas Pérez-Romero, Mar Domato Lluch & Manuel Gerónimo Pardo. (2018) Influence of propofol dose and blood components on duration of electrical seizures in electroconvulsive therapy. Brazilian Journal of Anesthesiology (English Edition) 68:6, pages 564-570.
Crossref
Crossref
María Luisa González Moral, Carmen Selva Sevilla, Patricia Romero Rodenas, María Teresa Tolosa Pérez, Marta Lucas Pérez‐Romero, Mar Domato Lluch & Manuel Gerónimo Pardo. (2018) Influência da dose de propofol e dos componentes sanguíneos na duração das convulsões elétricas em eletroconvulsoterapia. Brazilian Journal of Anesthesiology 68:6, pages 564-570.
Crossref
Crossref
Qin Xiang Ng. (2017) A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology 27:2, pages 112-116.
Crossref
Crossref
M. Köster, R. Grohmann, R. R. Engel, M. A. Nitsche, E. Rüther & D. Degner. (2013) Seizures during antidepressant treatment in psychiatric inpatients—results from the transnational pharmacovigilance project “Arzneimittelsicherheit in der Psychiatrie” (AMSP) 1993–2008. Psychopharmacology 230:2, pages 191-201.
Crossref
Crossref
Riccardo Polosa & Pasquale CaponnettoTobias Raupach. 2013. Advances in Smoking Cessation. Advances in Smoking Cessation
68
78
.
Viacheslav Terevnikov & Grigori Joffe. 2013. Polypharmacy in Psychiatry Practice, Volume I. Polypharmacy in Psychiatry Practice, Volume I
211
231
.
Tobias Raupach, Philippe H.J. Hoogsteder & Constant P. (Onno) van Schayck. (2012) Nicotine Vaccines to Assist with Smoking Cessation. Drugs 72:4, pages e1-e16.
Crossref
Crossref
Laura MattioliMarina Perfumi. (2009)
Evaluation of
Rhodiola rosea
L. extract on affective and physical signs of nicotine withdrawal in mice
. Journal of Psychopharmacology 25:3, pages 402-410.
Crossref
Crossref
Jae Yong Chung, Joo-Youn Cho, Hyeong-Seok Lim, Jung-Ryul Kim, Kyung-Sang Yu, Kyoung Soo Lim, Sang-Goo Shin & In-Jin Jang. (2011)
Effects of Pregnane X Receptor (
NR1I2
) and CYP2B6 Genetic Polymorphisms on the Induction of Bupropion Hydroxylation by Rifampin
. Drug Metabolism and Disposition 39:1, pages 92-97.
Crossref
Crossref
T. Javelot, H. Javelot, A. Baratta, L. Weiner, M. Messaoudi & P. Lemoine. (2010) Troubles psychotiques aigus liés au bupropion : revue de la littérature. L'Encéphale 36:6, pages 461-471.
Crossref
Crossref
Michael D. Faulx & Gary S. Francis. (2008) Adverse Drug Reactions in Patients with Cardiovascular Disease. Current Problems in Cardiology 33:12, pages 703-768.
Crossref
Crossref
Matthew J. Winter, William S. Redfern, Amanda J. Hayfield, Stewart F. Owen, Jean-Pierre Valentin & Thomas H. Hutchinson. (2008) Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs. Journal of Pharmacological and Toxicological Methods 57:3, pages 176-187.
Crossref
Crossref
Yan Chen, Nick C. Patel, Jeff J. Guo & Siyan Zhan. (2007) Antidepressant prophylaxis for poststroke depression: a meta-analysis. International Clinical Psychopharmacology 22:3, pages 159-166.
Crossref
Crossref
U. Werneke, S. Northey & D. Bhugra. (2006) Antidepressants and sexual dysfunction. Acta Psychiatrica Scandinavica 114:6, pages 384-397.
Crossref
Crossref
Linda P. Dwoskin, Anthony S. Rauhut, Kelley A. King‐Pospisil & Michael T. Bardo. (2007) Review of the Pharmacology and Clinical Profile of Bupropion, an Antidepressant and Tobacco Use Cessation Agent. CNS Drug Reviews 12:3-4, pages 178-207.
Crossref
Crossref
F. Rodríguez de Fonseca. (2006) Caso clínico de varón consumidor de 50 cigarrillos diarios. Trastornos Adictivos 8:3, pages 186-192.
Crossref
Crossref
Galya R. Abdrakhmanova, M. Imad Damaj, F. Ivy Carroll & Billy R. Martin. (2006) 2-Fluoro-3-(4-nitro-phenyl)deschloroepibatidine Is a Novel Potent Competitive Antagonist of Human Neuronal α4β2 nAChRs. Molecular Pharmacology 69:6, pages 1945-1952.
Crossref
Crossref